The survival rate for HER2 positive breast cancer is a very broad, general indication of outcomes only. Those who are learning about the survival rate for HER2 positive breast cancer should remember that it does not predict what will happen for any particular patient. Rather, the survival rate is an average based on a large number of patients with HER2 positive breast cancer. Therefore, the survival rate should only be used as a point of reference.
Survival rates are discussed in terms of years. For example, the five-year survival rate for HER2 positive breast cancer shows the percentage of patients who survive five years or longer following their diagnosis. It is likely that the survival rate for HER2 positive breast cancer will continue to improve as new and better treatments are developed, and patients who are diagnosed today are projected to have better outcomes than those whom the current survival rates are currently based on.
Factors that can influence survival rate
There are a number of lifestyle factors that can influence outcomes for women with HER2 positive breast cancer. To give themselves the best chance at achieving a favorable outcome, it is recommended that patients:
- Maintain a healthy weight
- Eat a healthy and balanced diet
- Remain physically active, if possible
- Avoid tobacco use
Moffitt Cancer Center is a leader in cancer research and treatment. We provide our patients with individualized treatment plans and a full range of supportive care services to ensure all their needs are met as they undergo treatment. As a result, we are able to achieve the best possible outcomes and quality of life for our patients.
Those who have questions about the survival rate for HER2 positive breast cancer are encouraged to consult with a physician at Moffitt. To request an appointment with or without a referral, call 1-888-663-3488 or submit a new patient registration form online.